These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Antineutrophil cytoplasmic antibodies in Estonian patients with inflammatory bowel disease. Prevalence and diagnostic role. Kull K; Salupere R; Uibo R; Ots M; Salupere V Hepatogastroenterology; 1998; 45(24):2132-7. PubMed ID: 9951879 [TBL] [Abstract][Full Text] [Related]
10. Antineutrophil cytoplasmic antibodies in relatives of patients with inflammatory bowel disease. Papo M; Quer JC; Pastor RM; García-Pardo G; Prats E; Mirapeix E; Rodríguez R; Richart C Am J Gastroenterol; 1996 Aug; 91(8):1512-5. PubMed ID: 8759652 [TBL] [Abstract][Full Text] [Related]
11. Anti-Saccharomyces cerevisiae mannan antibodies and antineutrophil cytoplasmic autoantibodies in Greek patients with inflammatory bowel disease. Koutroubakis IE; Petinaki E; Mouzas IA; Vlachonikolis IG; Anagnostopoulou E; Castanas E; Maniatis AN; Kouroumalis EA Am J Gastroenterol; 2001 Feb; 96(2):449-54. PubMed ID: 11232689 [TBL] [Abstract][Full Text] [Related]
12. A new type of perinuclear anti-neutrophil cytoplasmic antibody (p-ANCA) in active ulcerative colitis but not in Crohn's disease. Rump JA; Schölmerich J; Gross V; Roth M; Helfesrieder R; Rautmann A; Lüdemann J; Gross WL; Peter HH Immunobiology; 1990 Nov; 181(4-5):406-13. PubMed ID: 2099908 [TBL] [Abstract][Full Text] [Related]
13. Low prevalence of anti-neutrophil cytoplasmic antibodies in ulcerative colitis patients with long-term remission. Lindgren S; Florén CH; Lindhagen T; Starck M; Stewenius J; Nässberger L Eur J Gastroenterol Hepatol; 1995 Jun; 7(6):563-8. PubMed ID: 7552641 [TBL] [Abstract][Full Text] [Related]
14. Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease. Peeters M; Joossens S; Vermeire S; Vlietinck R; Bossuyt X; Rutgeerts P Am J Gastroenterol; 2001 Mar; 96(3):730-4. PubMed ID: 11280542 [TBL] [Abstract][Full Text] [Related]
15. Antineutrophil cytoplasmic antibodies in inflammatory bowel disease: diagnostic tool or research procedure? Andreani ML; Frascà G; Brusco G; Borgnino L; Biagi F; Gasbarrini G; Corazza GR Ann Ital Med Int; 1996; 11(4):254-7. PubMed ID: 9050283 [TBL] [Abstract][Full Text] [Related]
16. Anti-Saccharomyces cerevisiae mannan antibodies in inflammatory bowel disease: comparison of different assays and correlation with clinical features. Annese V; Piepoli A; Perri F; Lombardi G; Latiano A; Napolitano G; Corritore G; Vandewalle P; Poulain D; Colombel JF; Andriulli A Aliment Pharmacol Ther; 2004 Nov; 20(10):1143-52. PubMed ID: 15569117 [TBL] [Abstract][Full Text] [Related]
17. Phagocytosis, killing, lymphocyte-mediated antibacterial activity, serum autoantibodies, and plasma endotoxins in inflammatory bowel disease. Caradonna L; Amati L; Lella P; Jirillo E; Caccavo D Am J Gastroenterol; 2000 Jun; 95(6):1495-502. PubMed ID: 10894586 [TBL] [Abstract][Full Text] [Related]
18. [Significance of the determination of antineutrophil cytoplasmic antibodies (ANCA) in ulcerative colitis and Crohn's disease]. García-Herola A; Nos P; Hoyos M; Hinojosa J; Molés JR; Pascual S; Bustamante M; Sánchez Cuenca JM; Carmona E; Ponce J; Berenguer J Gastroenterol Hepatol; 1998 Apr; 21(4):169-73. PubMed ID: 9633176 [TBL] [Abstract][Full Text] [Related]
19. [Antineutrophil cytoplasmic antibodies (ANCA) in inflammatory diseases of the digestive tract]. Lamproye A; Belaiche J; Louis E; Salmon J; Mahieu P Acta Gastroenterol Belg; 1994; 57(2):171-6. PubMed ID: 8053303 [TBL] [Abstract][Full Text] [Related]
20. Antineutrophil cytoplasmic antibodies in Japanese patients with inflammatory bowel disease: prevalence and recognition of putative antigens. Sugi K; Saitoh O; Matsuse R; Tabata K; Uchida K; Kojima K; Nakagawa K; Tanaka S; Teranishi T; Hirata I; Katsu K Am J Gastroenterol; 1999 May; 94(5):1304-12. PubMed ID: 10235211 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]